We found that SB203580 and RPS6KA2-Sh synergistically inhibited p38/MAPK phosphorylation in ovarian cancer cells, while SB203580 partially rescued p38/MAPK activation caused by RPS6KA2-OE. The gene discussed is RPS6KA2; the disease is ovarian cancer.